[(3-Chloro-benzyl)-Methyl-aMino]-acetic acid
|
- $635 - $2013
- Product name: [(3-Chloro-benzyl)-Methyl-aMino]-acetic acid
- CAS: 1156268-64-2
- MF: C10H12ClNO2
- MW: 213.66
- EINECS:
- MDL Number:
- Synonyms:[(3-Chloro-benzyl)-Methyl-aMino]-acetic acid;Glycine, N-[(3-chlorophenyl)methyl]-N-methyl-
5 prices
Selected condition:
Brand
- aablocks
- Crysdot
Package
- 250mg
- 1g
- 5g
- Manufactureraablocks
- Product numberAA01FAH5
- Product description2-((3-Chlorobenzyl)(methyl)amino)acetic acid 95%
- Packaging5g
- Price$2013
- Updated2026-05-30
- Buy
- Manufactureraablocks
- Product numberAA01FAH5
- Product description2-((3-Chlorobenzyl)(methyl)amino)acetic acid 95%
- Packaging1g
- Price$760
- Updated2026-05-30
- Buy
- Manufactureraablocks
- Product numberAA01FAH5
- Product description2-((3-Chlorobenzyl)(methyl)amino)acetic acid 95%
- Packaging250mg
- Price$707
- Updated2026-05-30
- Buy
- ManufacturerCrysdot
- Product numberCD21018245
- Product description2-((3-Chlorobenzyl)(methyl)amino)acetic acid 97%
- Packaging1g
- Price$635
- Updated2026-05-27
- Buy
- ManufacturerCrysdot
- Product numberCD21018245
- Product description2-((3-Chlorobenzyl)(methyl)amino)aceticacid 97%
- Packaging1g
- Price$635
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| aablocks | AA01FAH5 | 2-((3-Chlorobenzyl)(methyl)amino)acetic acid 95% | 5g | $2013 | 2026-05-30 | Buy |
| aablocks | AA01FAH5 | 2-((3-Chlorobenzyl)(methyl)amino)acetic acid 95% | 1g | $760 | 2026-05-30 | Buy |
| aablocks | AA01FAH5 | 2-((3-Chlorobenzyl)(methyl)amino)acetic acid 95% | 250mg | $707 | 2026-05-30 | Buy |
| Crysdot | CD21018245 | 2-((3-Chlorobenzyl)(methyl)amino)acetic acid 97% | 1g | $635 | 2026-05-27 | Buy |
| Crysdot | CD21018245 | 2-((3-Chlorobenzyl)(methyl)amino)aceticacid 97% | 1g | $635 | 2021-12-16 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|




